Tumor localization and antitumor efficacy of novel sapphyrin compounds

Molecular Cancer Therapeutics

Volumn 5, Issue 11, 2006, Pages 2798-2805

  Naumovski, Louie ^a   Sirisawad, Mint ^a   Lecane, Philip ^a   Chen, Jun ^a   Ramos, Jason ^a   Wang, Zhong ^a   Cortez, Cecilia ^a   Magda, Darren ^a   Thiemann, Patti ^a   Boswell, Garry ^a   Miles, Dale ^a   Cho, Dong Gyu ^b   Sessler, Jonathan L ^b   Miller, Richard ^a  

^a PHARMACYCLICS INC   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYL GROUP; ANTINEOPLASTIC AGENT; MANNITOL; PCI 2000; PCI 2050; PCI 2051; PCI 2052; PCI 2053; PORPHYRIN DERIVATIVE; PYRROLE; SAPPHYRIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; BONE MARROW SUPPRESSION; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG UPTAKE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HEMATOLOGIC DISEASE; IMMUNE DEFICIENCY; INJECTION; INJECTION SITE IRRITATION; KIDNEY DISEASE; LIVER DISEASE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; TUMOR CELL; TUMOR LOCALIZATION; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; MICE; NEOPLASMS; PORPHYRINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33845228326     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0246     Document Type: Article

References (16)

1. Sessler JL, Tvemoes NA, Davis J, et al. Expanded porphyrins. Synthetic materials with potential medical utility. Pure Appl Chem 1999; 71:2009-18.
2. Sessler JL, Davis JM. Sapphvrins: versatile anion binding agents. Acc Chem Res 2001;34:989-97.
3. Sessler JL, Davis JM, Kral V, Kimbrough T, Lynch V. Water soluble sapphyrins: potential fluorescent phosphate anion sensors. Org Biomol Chem 2003;1:4113-23.
4. Synytsya A, Kral V, Blechova M, Volka K. Biolocalisation and photochemical properties of two novel macrocyclic photosensitisers: a spectroscopic study. J Photochem Photobiol B 2004;74:73-84.
5. Parmeswaran D, Pushpan SK, Srinivasan A, Ravi KM, Chandrashekar TK, Ganesan S. In vitro and in vivo investigations on the photodynamic activity of core-modified expanded porphyrin-ammonium salt of 5,10,15,20-tetrakis-(meso-p-sulfonato phenyl)-25,27,29-trithia sapphyrin. Photochem Photobiol 2003;78:487-95.
6. Judy MM, Matthews JL, Newman JT, et al. In vitro photodynamic inactivation of herpes simplex virus with sapphyrins: 22 pi-electron porphyrin-like macrocycles. Photochem Photobiol 1991;53:101-7.
7. Roitman L, Ehrenberg B, Nitzan Y, Kral V, Sessler JL. Spectroscopy and photosensitization of sapphyrins in solutions and biological membranes. Photochem Photobiol 1994;60:421-6.
8. Kral V, Davis J, Andrievsky A, et al. Synthesis and biolocalization of water-soluble sapphyrins. J Med Chem 2002;45:1073-8.
9. Naumovski L, Ramos J, Sirisawad M, et al. Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activity. Mol Cancer Ther 2005;4:968-76.
10. Shevchuk SV, Davis JM, Sessler A. Synthesis of sapphyrins via a "3 + 1 + 1" procedure. Tetrahedron Lett 2001;42:2447-50.
11. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
12. Nelson JA, Schmiedl U. Porphyrins as contrast media. Magn Reson Med 1991;22:366-71.
13. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004;68:320-44.
14. Wade T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004;23:2838-49.
15. Bohmer RM, Morstyn G. Uptake of hematoporphyrin derivative by normal and malignant cells: effect of serum, pH, temperature, and cell size. Cancer Res 1985;45:5328-34.
16. Greenwald RB, Choe YH, McGuire J, Conover CD. Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev 2003;55: 217-50.